- Home
- SITC vs SLP Comparison
SITC vs SLP Comparison
Compare SITC & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SITC | SLP |
|---|---|---|
| Founded | 1965 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | EDP Services |
| Sector | Real Estate | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 391.8M | 322.4M |
| IPO Year | 1993 | 1997 |
Fundamental Metrics
Financial Performance| Metric | SITC | SLP |
|---|---|---|
| Price | $6.33 | $19.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $10.83 | ★ $28.00 |
| AVG Volume (30 Days) | ★ 1.8M | 303.1K |
| Earning Date | 02-26-2026 | 01-08-2026 |
| Dividend Yield | ★ 103.85% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.54 | N/A |
| Revenue | ★ $139,962,000.00 | $78,676,000.00 |
| Revenue This Year | N/A | $2.42 |
| Revenue Next Year | N/A | $7.05 |
| P/E Ratio | $11.96 | ★ N/A |
| Revenue Growth | N/A | ★ 5.70 |
| 52 Week Low | $6.21 | $12.39 |
| 52 Week High | $15.93 | $37.67 |
Technical Indicators
Market Signals| Indicator | SITC | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 37.72 | 58.53 |
| Support Level | $6.21 | $16.00 |
| Resistance Level | $6.55 | $20.07 |
| Average True Range (ATR) | 0.14 | 1.03 |
| MACD | 0.04 | 0.07 |
| Stochastic Oscillator | 25.97 | 95.70 |
Price Performance
Historical ComparisonAbout SITC SITE Centers Corp.
SITE Centers Corp is a self-administered and self-managed REIT that operates as a fully integrated real estate company. The company is engaged in the business of owning, leasing, acquiring, redeveloping, developing and managing shopping centers.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.